Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs. Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance ...
SAN DIEGO, Aug. 24, 2017 /PRNewswire/ -- Ajinomoto Althea, Inc. ("Althea"), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the ...
Advancing Aseptic Precision: How Modern Filling Lines Elevate Sterility, Flexibility, and Throughput
Isolator-based Grade A/ISO 5 architectures minimize operator interventions, enabling robust contamination control and compliance with EU GMP Annex 1, FDA guidance, PIC/S, and ISO 14644. Lyophilization ...
ROCKVILLE, Md.--(BUSINESS WIRE)--ABL, Inc. (ABL), a leading contract research, development and biomanufacturing organization to the biopharmaceutical industry worldwide, is proud to announce the ...
Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations.
Lonza, announced the operational readiness of its new aseptic drug product filling line in Stein (CH). The filling line was granted a GMP license following Swissmedic approval, strengthening Lonza’s ...
In line with Dalton's ongoing mission to adopt cutting-edge technology, this strategic investment not only expands the collaboration between the two organisations, but it also enables Toronto-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results